Alysophil offers an AI‑enhanced continuous‑flow chemistry platform that automates reaction screening, safety monitoring, and process optimization. The system uses machine‑learning models and real‑time data to design cost‑effective, low‑risk synthetic routes and accelerate scale‑up for chemical manufacturers.
Funding
Funding not disclosed
Founders
Product
Problem
Chemical manufacturers face pressure to develop new molecules quickly while reducing safety risks, production costs, and environmental impact. Traditional batch processes often lack the flexibility and data integration needed for rapid, sustainable innovation.
Solution
Alysophil provides an AI‑enhanced flow chemistry platform that combines continuous‑flow reactors with machine‑learning‑driven process optimization. The system uses real‑time data collection and predictive models to design safe, cost‑effective synthetic routes and to accelerate scale‑up from laboratory to industrial production. By integrating safety monitoring, resource‑efficient operation, and agile workflow management, the platform helps manufacturers bring novel compounds to market faster while meeting regulatory and sustainability requirements.
Target Audience
Primary customers are chemical manufacturers and process development teams seeking to accelerate the creation of new compounds with lower risk and cost.
Features
- Continuous‑flow reactor hardware optimized for rapid reaction screening and scale‑up
- AI algorithms that generate and evaluate synthetic pathways for novel molecules
- Real‑time safety monitoring and automated risk mitigation controls
- Data‑driven optimization engine that minimizes reagent usage and energy consumption
- Integrated workflow tools for agile process development and rapid iteration
- Cloud‑based analytics dashboard for tracking performance, cost, and environmental metrics